Search research articles
Contact Us
Filters
Showing results (1-10 of 96) with videos related to
Page
of 10
Sort By:
Expert Opinion on Pharmacotherapy
|
March 11, 2021
Evaluating the combination of emtricitabine/ tenofovir alafenamide fumarate to reduce the risk of sexually acquired HIV-1-infection in at-risk adults
Thibault Mesplède
Expert Opinion on Investigational Drugs
|
November 16, 2018
Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update
Yingshan Han, Thibault Mesplède
Viruses
|
July 23, 2015
Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence
Thibault Mesplède, Mark A Wainberg
Expert Opinion on Pharmacotherapy
|
January 31, 2019
Bictegravir in a fixed-dose tablet with emtricitabine and tenofovir alafenamide for the treatment of HIV infection: pharmacology and clinical implications
Hanh Thi Pham, Thibault Mesplède
Infectious Diseases and Therapy
|
August 20, 2014
Integrase Strand Transfer Inhibitors in HIV Therapy
Thibault Mesplède, Mark A Wainberg
Viruses
|
August 29, 2014
Is resistance to dolutegravir possible when this drug is used in first-line therapy?
Thibault Mesplède, Mark A Wainberg
Expert Review of Anti-Infective Therapy
|
January 20, 2018
Where are we with injectables against HIV infection and what are the remaining challenges?
Said A Hassounah, Thibault Mesplède
Drugs in Context
|
March 3, 2018
The latest evidence for possible HIV-1 curative strategies
Hanh Thi Pham, Thibault Mesplède
Ebiomedicine
|
July 19, 2016
Will LEDGIN molecules be able to play a role in a cure for HIV infection?
Thibault Mesplède, Mark A Wainberg
Expert Opinion on Investigational Drugs
|
January 30, 2020
Combination therapies currently under investigation in phase I and phase II clinical trials for HIV-1
Hanh Thi Pham, Subin Yoo, Thibault Mesplède
Page
of 10
Search research articles
Search
Showing results (1-10 of 96) with videos related to
Sort By:
Page
of 10
Expert Opinion on Pharmacotherapy
|
March 11, 2021
Evaluating the combination of emtricitabine/ tenofovir alafenamide fumarate to reduce the risk of sexually acquired HIV-1-infection in at-risk adults
Thibault Mesplède
Expert Opinion on Investigational Drugs
|
November 16, 2018
Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update
Yingshan Han, Thibault Mesplède
Viruses
|
July 23, 2015
Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence
Thibault Mesplède, Mark A Wainberg
Expert Opinion on Pharmacotherapy
|
January 31, 2019
Bictegravir in a fixed-dose tablet with emtricitabine and tenofovir alafenamide for the treatment of HIV infection: pharmacology and clinical implications
Hanh Thi Pham, Thibault Mesplède
Infectious Diseases and Therapy
|
August 20, 2014
Integrase Strand Transfer Inhibitors in HIV Therapy
Thibault Mesplède, Mark A Wainberg
Viruses
|
August 29, 2014
Is resistance to dolutegravir possible when this drug is used in first-line therapy?
Thibault Mesplède, Mark A Wainberg
Expert Review of Anti-Infective Therapy
|
January 20, 2018
Where are we with injectables against HIV infection and what are the remaining challenges?
Said A Hassounah, Thibault Mesplède
Drugs in Context
|
March 3, 2018
The latest evidence for possible HIV-1 curative strategies
Hanh Thi Pham, Thibault Mesplède
Ebiomedicine
|
July 19, 2016
Will LEDGIN molecules be able to play a role in a cure for HIV infection?
Thibault Mesplède, Mark A Wainberg
Expert Opinion on Investigational Drugs
|
January 30, 2020
Combination therapies currently under investigation in phase I and phase II clinical trials for HIV-1
Hanh Thi Pham, Subin Yoo, Thibault Mesplède
Page
of 10